Tarsus Pharmaceuticals (TARS)
71.55
+1.05 (1.49%)
Upcoming Events
Latest Headlines
Lisata Therapeutics adds Jeffrey Farrow to its board of directors
October 14, 2026 4:05 PM - StreetInsider
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
October 14, 2026 4:05 PM - StreetInsider
Tarsus Pharmaceuticals (TARS) files for up to 2.91M share offering by selling stockholders
October 13, 2026 5:05 PM - StreetInsider
Form S-3ASR Tarsus Pharmaceuticals,
October 13, 2026 5:03 PM - SEC Filing
Tarsus Pharmaceuticals (TARS) files for up to 2.23M share offering by selling stockholders
October 13, 2026 4:32 PM - StreetInsider
Form S-3ASR Tarsus Pharmaceuticals,
October 13, 2026 4:30 PM - SEC Filing
Form 8-K/A Tarsus Pharmaceuticals, For: Sep 04
October 13, 2026 4:01 PM - SEC Filing
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
September 29, 2026 8:30 AM - StreetInsider
Goldman Sachs Assumes Tarsus Pharmaceuticals (TARS) at Buy
September 24, 2026 5:00 AM - StreetInsider
Form 4 Tarsus Pharmaceuticals, For: Sep 15 Filed by: PYOTT DAVID E I
September 17, 2026 4:48 PM - SEC Filing
Form 4 Tarsus Pharmaceuticals, For: Sep 15 Filed by: YARNO WENDY L
September 17, 2026 4:23 PM - SEC Filing
Form 4 Tarsus Pharmaceuticals, For: Sep 15 Filed by: LINK WILLIAM J PHD
September 17, 2026 4:23 PM - SEC Filing
Barclays Reinstates Tarsus Pharmaceuticals (TARS) at Overweight
September 16, 2026 4:45 AM - StreetInsider
Form 144 Tarsus Pharmaceuticals, Filed by: LINK WILLIAM J PHD
September 15, 2026 4:52 PM - SEC Filing
Form 8-K Tarsus Pharmaceuticals, For: Sep 04
September 10, 2026 4:07 PM - SEC Filing
Tarsus Pharmaceuticals (TARS) PT Raised to $105 at Jefferies
September 8, 2026 1:41 PM - StreetInsider
Tarsus to Participate in Upcoming Investor Conferences
September 1, 2026 4:30 PM - StreetInsider
Form 144 Tarsus Pharmaceuticals, Filed by: Mottiwala Aziz
August 25, 2026 4:20 PM - SEC Filing
Form 144 Tarsus Pharmaceuticals, Filed by: Mottiwala Aziz
August 19, 2026 2:28 PM - SEC Filing
Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: Janus Henderson Group Ltd.
August 13, 2026 12:47 PM - SEC Filing
Tarsus Pharmaceuticals (TARS) PT Raised to $100 at Oppenheimer
August 12, 2026 7:51 AM - StreetInsider
Tarsus Pharmaceuticals (TARS) PT Raised to $100 at Mizuho
August 10, 2026 7:13 AM - StreetInsider
Tarsus Pharmaceuticals, Inc. (TARS) Misses Q2 EPS by 21c
August 6, 2026 8:27 AM - StreetInsider
Form 10-Q Tarsus Pharmaceuticals, For: Jun 30
August 6, 2026 7:26 AM - SEC Filing
Form 8-K Tarsus Pharmaceuticals, For: Aug 06
August 6, 2026 7:23 AM - SEC Filing
Form 8-K Tarsus Pharmaceuticals, For: Aug 05
August 6, 2026 7:12 AM - SEC Filing
Form 8-K Tarsus Pharmaceuticals, For: Jul 31
August 6, 2026 7:08 AM - SEC Filing
Tarsus Pharmaceuticals posts 69% sales jump, raises 2026 guidance
August 6, 2026 7:06 AM - StreetInsider
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
August 6, 2026 7:03 AM - StreetInsider
Tarsus Pharmaceuticals raises $125M in oversubscribed PIPE financing
August 6, 2026 7:02 AM - StreetInsider
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
August 6, 2026 7:02 AM - StreetInsider
Tarsus Pharmaceuticals to acquire Alkeus for up to $800M
August 6, 2026 7:01 AM - StreetInsider
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
August 6, 2026 7:01 AM - StreetInsider
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
August 5, 2026 8:02 PM - Globe NewsWire
Tarsus Pharmaceuticals (TARS) PT Lowered to $98 at Mizuho
August 3, 2026 6:37 AM - StreetInsider
Tarsus Pharmaceuticals (TARS) PT Lowered to $98 at Mizuho
July 31, 2026 6:53 AM - StreetInsider
Full Article List
